Minerva Neurosciences (NERV) Shares Issued (2015 - 2026)

Minerva Neurosciences (NERV) reported Shares Issued of $1.2 million for Q1 2026, up 110.52% quarter-over-quarter from -$11.4 million in Q4 2020.

Minerva Neurosciences (NERV) Shares Issued (2015 - 2026) Analysis & Trends

Minerva Neurosciences has reported Shares Issued for 7 years, with the latest figure at $1.2 million in Q1 2026.

For the quarter ending Q1 2026, Shares Issued changed N/A year-over-year to $1.2 million; the trailing twelve-month figure through Mar 2026 stood at -$10.2 million (changed N/A YoY), and the FY2025 full-year result was $80.0 million, changed N/A from the prior year.
Shares Issued for Q1 2026 stood at $1.2 million, up from -$11.4 million in the prior quarter.
The five-year high for Shares Issued was $1.2 million in Q1 2026, with the low at $1.2 million in Q1 2026.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Shares Issued (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-	-
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-	5.40 Mn
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn	-
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-	-
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-	-
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-	-
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn	27.00 Mn
9	Abivax	91.96 Bn	91.96 Bn	-	26,927.15
10	Minerva Neurosciences	197.55 Mn	197.55 Mn	-	1.20 Mn

Download Data